Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) regularly issues news and updates that shed light on its role as the world’s largest diversified manufacturer of professional dental products and technologies. Company press releases cover topics such as strategic partnerships, leadership changes, financial results and portfolio decisions, giving investors and dental professionals insight into how the business is evolving.
Recent news has highlighted Dentsply Sirona’s focus on connected dentistry and technology-enabled solutions. The company has announced expanded and renewed distribution partnerships in the United States that provide access to its dental technology portfolio, including systems and imaging solutions referenced in those agreements. These announcements emphasize integrated ecosystems that connect devices, software and services from scanning through design and manufacturing workflows.
News items also address corporate strategy and performance, including quarterly financial results and the introduction of a Return-to-Growth action plan. In these updates, Dentsply Sirona outlines priorities such as putting customers at the center, strengthening the U.S. business, and evolving operations to support innovation and training. Leadership appointments in commercial, finance and regional roles are frequently reported, reflecting the company’s efforts to align its organization with these priorities.
Other press releases describe decisions about the Wellspect Healthcare business, dividend declarations, participation in investor conferences and the conclusion of an SEC Division of Enforcement investigation without enforcement action. Together, these news items provide a detailed view of how Dentsply Sirona manages its portfolio, governance and capital allocation. Readers interested in XRAY can use this news feed to follow developments in connected dentistry, strategic partnerships, governance actions and financial communications from the company.
Dentsply Sirona (XRAY) has initiated a strategic review of its Wellspect Healthcare business, a leading provider of bladder and bowel management care products. Wellspect has demonstrated strong performance with mid-to-high single-digit organic sales growth in 2023 and through Q3 2024, operating in an estimated $2 billion total addressable market.
The company has invested in strengthening Wellspect's foundation through product innovation, profitable revenue growth, and capacity expansion. The strategic review aims to unlock value for stakeholders while allowing Dentsply Sirona to focus on its core dental business. Goldman Sachs is serving as financial advisor, and the company will report Q4 and full-year 2024 results on February 27, 2025.
Dentsply Sirona (XRAY) has appointed two new members to its Board of Directors: Michael J. Barber and Daniel T. Scavilla, effective February 5, 2025. Barber, with over 40 years of experience in product management and innovation at GE, will join the Science and Technology Committee. Scavilla, currently CEO of Globus Medical, will serve on the Audit and Finance Committee.
The appointments come as Dr. Dorothea Wenzel steps down from the board due to increased demands from her recently announced chair nomination. With these changes, the board size increases from 10 to 11 members. Over the past two years, the company has added four new board members as part of its ongoing board refresh strategy to support its transformation in dentistry.
Dentsply Sirona (XRAY) has announced its upcoming investor conference call and live webcast scheduled for Thursday, February 27, 2025, at 8:30 am ET. The event will focus on reviewing the company's fourth quarter and full year 2024 financial results.
Investors and interested parties can access a presentation related to the call through the Investors section of Dentsply Sirona's website. The company has provided multiple ways to participate in the event, including a live webcast available on their investor relations website and a registration link for those planning to join the call directly.
Following the conference call, a webcast replay will be made available on the company's Investors section for those unable to attend the live event.
Dentsply Sirona (Nasdaq: XRAY) announced the repositioning of its Byte business model, emphasizing expanded in-person dentist oversight for treatments. The company aims to leverage Byte's direct-to-consumer (DTC) demand generation capabilities, enhance digital customer journey management, and improve customer service and marketing across its aligner portfolio. Dentsply Sirona will not reinstate at-home Byte Aligner Systems and Impression Kits but will continue to support existing non-contraindicated patients. The company will work with regulatory authorities to obtain necessary clearances before any market launch. CEO Simon Campion highlighted the company's commitment to quality, compliance, and broad access to care. Dentsply Sirona will present this strategy at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025. Presentation materials and a webcast replay will be available on the company's investor website.
Dentsply Sirona (XRAY) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team is scheduled to deliver their presentation on Wednesday, January 15, 2025, at 7:30 am PT (10:30 am ET).
Interested parties, including investors, will have access to both a live audio webcast and a webcast replay of the presentation through the Investors section of Dentsply Sirona's website at investor.dentsplysirona.com.
Dentsply Sirona (Nasdaq: XRAY) has announced a quarterly cash dividend declaration by its Board of Directors. The company will pay $0.16 per share of common stock, which indicates an annual rate of $0.64 per share. Shareholders who are holders of record as of December 27, 2024, will receive the dividend payment on January 10, 2025.
Dentsply Sirona (Nasdaq: XRAY) has announced its participation in the 7th Annual Evercore ISI HealthCONx Conference. The company's management will engage in a fireside chat discussion on December 5, 2024, at 8:20 am ET. Interested parties can access both the live audio webcast and replay through the Investors section of Dentsply Sirona's website at investor.dentsplysirona.com.
Dentsply Sirona (Nasdaq: XRAY) has appointed Herman V. Cueto as Interim Chief Financial Officer, effective immediately. Cueto brings over 20 years of experience in healthcare finance leadership. He will oversee the finance organization while the company conducts its search for a permanent CFO. CEO Simon Campion expressed confidence in Cueto's financial acumen, operational expertise, and understanding of the global healthcare sector to help execute strategic priorities during this transition period.
Dentsply Sirona (XRAY) reported Q3 2024 results with net sales of $951 million, up 0.5% year-over-year, with organic sales growth of 1.3%. The company posted a GAAP net loss of ($494) million, or ($2.46) per share, including a non-cash goodwill impairment charge of ($495) million. Adjusted EPS was $0.50, slightly up from $0.49 in Q3 2023. Due to market pressures in U.S. equipment and challenges with Byte, the company revised its FY24 outlook, now expecting organic sales decline of (3.5%) to (2.5%) and adjusted EPS of $1.82 to $1.86.
Dentsply Sirona (Nasdaq: XRAY) has announced a conference call and live webcast scheduled for October 25, 2024, at 9:00 am ET to discuss their Byte Aligner business. Interested participants can register for the call through the provided registration link. A replay of the webcast will be made available in the Investors section of the company's website after the call concludes.